|
Real-time Estimate
Cboe BZX
21:35:14 20/08/2026 HKT
|
5-day change | 1st Jan Change | ||
| 548.40 USD | -0.66% |
|
+5.01% | +21.77% |
| 08-12 | Vertex Has Multiple Portfolio Catalysts With Favorable Risk-Reward, RBC Says | MT |
| 08-11 | Jefferies Adjusts Price Target on Vertex Pharmaceuticals to $633 From $610, Maintains Buy Rating | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 563.12 | +2% | 25 | ||||||
| 1,310.9 | +2.39% | 28 | ||||||
| 272.5 | -0.33% | 22 | ||||||
| 276.59 | +3.99% | 29 | ||||||
| 370.31 | +0.79% | 18 | ||||||
| 154.11 | -2.89% | 21 | ||||||
| 212.3 | +29.47% | 22 | ||||||
| 388.48 | -12.18% | 29 | ||||||
| 313.7 | +4.76% | 24 | ||||||
| 157.41 | +6.64% | 27 | ||||||
| 28.61 | +1.3% | 26 | ||||||
| 66.21 | -2.07% | 24 | ||||||
| 94.28 | +20.01% | 23 | ||||||
| 21.61 | +12.8% | 20 | ||||||
| 9,350 | +35.8% | 15 | ||||||
| 6,450.19 | +11.81% | 16 | ||||||
| 56.83 | +15.96% | 18 | ||||||
| 79.25 | +50.5% | 16 | ||||||
| 41.4 | +10.49% | 10 | ||||||
| 4.208 | +17.58% | 17 | ||||||
| Average | 1,010.6 | +10.44% | 22 | ||||||
| Weighted average by Cap. | 705.65 | +4.64% | 24 |
- Stock Market
- Stocks
- VRTX Stock
- Sector Vertex Pharmaceuticals Incorporated
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
